Adapting, Adopting, and Succeeding in a Decentralized Landscape
Watch now, as leaders across the research community discuss the exponential evolution of clinical trials, uncover trends observed across the industry, and hear how leading research organizations have adapted to a decentralized landscape.
Decentralized clinical trials are gaining momentum as sponsors, CROs, vendors, and sites work to adopt remote workflows and remove participation barriers in clinical research. Despite its increased popularity, conducting decentralized research is undefined, and many industry stakeholders are still working to overcome operational and regulatory challenges.
In this expert panel discussion, representatives from industry, research sites, and academia explore the impact of decentralized models on the research landscape. This includes discussing observed trends at the site and sponsor level, examining obstacles to conducting innovative research, and proposing opportunities for improvement that still remain.
Learning Objectives:
- Recognize key impacts of decentralized trials on your research operations and regulatory processes
- Explore lessons learned from some of the research industry’s biggest players in their efforts to adapt to and adopt decentralized workflows
- Discuss the evolving roles and responsibilities of sponsors, CROs, and sites in training, technology, inclusion of underserved populations, and more
- Review practical strategies to bring back to your organization to better conduct decentralized research
Cost to Attend:
Free
Hosted By
Robann Cunningham
Chief Commercial Officer
Advarra
Panelists
Bernadette Tosti
VP Patient Experience
Science37
Patricia Salter
Head of DCT Operations
IQVIA
Rosamund Round
VP Patient Innovation Center and Decentralized Trials
Parexel
John Reites
CEO
THREAD Research
Paul Evans
President & CEO
Velocity
Marissa Stroo
Director of Clinical Operations - Data
Duke University
DATE: November 4, 2021
Time: 1 pm ET | 10 am PT
Duration: 90 minutes